Digital Health And Non-Opioid Therapies Will Transform Pain Management
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 4 Analysts
Published
23 Aug 25
Updated
23 Aug 25
AnalystHighTarget's Fair Value
US$3.00
73.8% undervalued intrinsic discount23 Aug
US$0.79
1Y
-37.1%7D
-3.1%1Y
-37.1%7D
-3.1%